Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer

Cecilia Wei Lin Lee1, Kosei Ito, Yoshiaki Ito

  • 1Cancer Science Institute of Singapore and NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore.

Cancer Research
|May 6, 2010
PubMed

Insights

Bone morphogenetic proteins (BMPs) suppress colorectal cancer growth by upregulating RUNX3, which inhibits the c-Myc oncogene. This pathway involves RUNX3 directly reducing c-Myc and indirectly through beta-catenin signaling.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • Bone morphogenetic proteins (BMPs) are crucial signaling molecules in the transforming growth factor-beta (TGF-beta) superfamily.
  • Aberrations in BMP signaling pathways are implicated in intestinal cancer, with mutations found in BMP receptor 1a and Smad4.
  • RUNX3, a tumor suppressor, acts downstream of TGF-beta and BMP signaling, modulating beta-catenin/T-cell factor (TCF) activity.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the tumor-suppressive function of the BMP pathway via RUNX3 in colorectal carcinogenesis.
  • To elucidate how BMP signaling impacts colorectal cancer cell growth and oncogene expression.

Main Methods:

  • Utilized the human colorectal cancer cell line HT-29.
  • Assessed the effects of BMP and RUNX3 on cell growth and c-Myc oncogene expression.
  • Investigated the regulatory role of RUNX3 in c-Myc expression through transcriptional and beta-catenin/TCF pathways.

Main Results:

  • BMP demonstrated a significant growth-suppressive effect on HT-29 colorectal cancer cells.
  • BMP and/or RUNX3 were found to downregulate the expression of the c-Myc oncogene.
  • Upregulation of RUNX3 by BMP led to reduced c-Myc expression, mediated by direct transcriptional inhibition and attenuation of beta-catenin/TCF signaling.

Conclusions:

  • The BMP pathway, through RUNX3, exerts tumor-suppressive effects in colorectal cancer.
  • RUNX3 inhibits colorectal cancer progression by downregulating c-Myc expression via multiple mechanisms.
  • Targeting the BMP/RUNX3/c-Myc axis presents a potential therapeutic strategy for colorectal cancer.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...